Estrella Immunopharma EPS ESLA

Diluted earnings per share by quarter and over the last twelve months, from 2021.

Estrella Immunopharma's earnings per share was −$0.25 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.05.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.05	n/a	−$0.25
Q1 FY26	Mar 31, 2026	−$0.05	n/a	−$0.35
Q4 FY25	Dec 31, 2025	−$0.02	n/a	−$0.36
Q3 FY25	Sep 30, 2025	−$0.13	n/a	−$0.37
Q2 FY25	Jun 30, 2025	−$0.15	n/a	−$0.33
Q1 FY25	Mar 31, 2025	−$0.06	n/a	−$0.29
Q4 FY24	Dec 31, 2024	−$0.03	n/a	−$0.24
Q2 FY24	Sep 30, 2024	−$0.09	n/a	−$0.24
Q4 FY24	Jun 30, 2024	−$0.11	n/a	−$1.93
Q3 FY24	Mar 31, 2024	−$0.01	n/a	−$1.95
Q2 FY24	Dec 31, 2023	−$0.03	n/a	−$10.07
Q1 FY24	Sep 30, 2023	−$1.78	n/a	−$26.37

Companies in Healthcare nearest Estrella Immunopharma's size, closest first, today.

Company	EPS, 12 months	Growth
ESLAEstrella Immunopharma	−$0.25
ATNMActinium Pharmaceuticals	$0.36
NEPHNephros	$0.16	+33% a year
APTAlpha Pro Tech	$0.41	+24% a year
SPROSpero Therapeutics	$0.11
LFVNLifevantage	$0.40	−46% a year
ICCCImmucell	$0.08	−58% a year
KEQUKewaunee Scientific	$2.76	−33% a year
PDEXPro DEX	$4.11	+52% a year
PLXProtalix BioTherapeutics	$0.23	+283% a year
NATRNatures Sunshine Products	$1.01	+36% a year
Peer median	$0.38